1. Randomized clinical trial: Nucleos(t)ide analogues improved survival of CHB-related HCC patients via reducing severity and progression of malignancy
   Yun Wang et al, 2016, Oncotarget CrossRef
2. Risk factors for early mortality after hepatectomy for hepatocellular carcinoma
   Chao-Wei Lee et al, 2016, Medicine CrossRef
3. Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects
   Ming Hong et al, 2015, International Journal of Molecular Sciences CrossRef
4. ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system
   Chaohui Zuo et al, 2016, Oncotarget CrossRef
5. Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma
   Jiang Chen et al, 2015, Cancer Letters CrossRef
6. Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma
   Peng Wang et al, 2023, BMC Cancer CrossRef
7. Infection and cancer in multicellular organisms
   Paul W. Ewald et al, 2015, Philosophical Transactions of the Royal Society B: Biological Sciences CrossRef
8. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
   Weiwei Tang et al, 2020, Signal Transduction and Targeted Therapy CrossRef
9. The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: Incidence, long-term outcomes and predictive factors
   Zhi-Qin Li et al, 2017, Clinics and Research in Hepatology and Gastroenterology CrossRef
10. Tenofovir decrease hepatocellular carcinoma recurrence in chronic hepatitis B patients after liver resection
    Min Zhang et al, 2018, Infectious Agents and Cancer CrossRef
11. New insights on sorafenib resistance in liver cancer with correlation of individualized therapy
    Zhang Cheng et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
12. Effect of Nucleos(t)ide Analogs on Patients with Intermediate and Advanced Hepatitis B Virus-Related Hepatocellular Carcinoma
    Zhi-Wei Jian et al, 2019, Digestive Diseases and Sciences CrossRef
13. The progress and prospects of routine prophylactic antiviral treatment in hepatitis B-related hepatocellular carcinoma
    Enze Jiang et al, 2016, Cancer Letters CrossRef
14. Comorbidities in patients with chronic hepatitis C and hepatitis B on hemodialysis
    Po‐Yao Hsu et al, 2021, Journal of Gastroenterology and Hepatology CrossRef
15. Comparing the clinicopathological characteristics of combined hepatocellular–cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification
    Chih‐Chieh Yen et al, 2021, Histopathology CrossRef